136 related articles for article (PubMed ID: 37345564)
1. SARS-CoV-2 omicron RBD forms a weaker binding affinity to hACE2 compared to Delta RBD in
Le HT; Tran LH; Phung HTT
J Biomol Struct Dyn; 2024 May; 42(8):4087-4096. PubMed ID: 37345564
[TBL] [Abstract][Full Text] [Related]
2. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
[TBL] [Abstract][Full Text] [Related]
3. Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2.
Han P; Li L; Liu S; Wang Q; Zhang D; Xu Z; Han P; Li X; Peng Q; Su C; Huang B; Li D; Zhang R; Tian M; Fu L; Gao Y; Zhao X; Liu K; Qi J; Gao GF; Wang P
Cell; 2022 Feb; 185(4):630-640.e10. PubMed ID: 35093192
[TBL] [Abstract][Full Text] [Related]
4. Structural basis and analysis of hamster ACE2 binding to different SARS-CoV-2 spike RBDs.
Niu S; Zhao Z; Liu Z; Rong X; Chai Y; Bai B; Han P; Shang G; Ren J; Wang Y; Zhao X; Liu K; Tian W-x; Wang Q; Gao GF
J Virol; 2024 Mar; 98(3):e0115723. PubMed ID: 38305152
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
Nayak SK
Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
[TBL] [Abstract][Full Text] [Related]
6. E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies: Binding free energy calculation studies.
Wang WB; Liang Y; Jin YQ; Zhang J; Su JG; Li QM
J Mol Graph Model; 2021 Dec; 109():108035. PubMed ID: 34562851
[TBL] [Abstract][Full Text] [Related]
7. Improved Binding Affinity of Omicron's Spike Protein for the Human Angiotensin-Converting Enzyme 2 Receptor Is the Key behind Its Increased Virulence.
Kumar R; Murugan NA; Srivastava V
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328828
[TBL] [Abstract][Full Text] [Related]
8. Molecular Insights into the Variability in Infection and Immune Evasion Capabilities of SARS-CoV-2 Variants: A Sequence and Structural Investigation of the RBD Domain.
Wang TH; Shao HP; Zhao BQ; Zhai HL
J Chem Inf Model; 2024 Apr; 64(8):3503-3523. PubMed ID: 38517012
[TBL] [Abstract][Full Text] [Related]
9. Molecular insights into the binding interactions and energetics of the omicron spike variant with hACE2 and a neutralizing antibody.
Kumar V; Shefrin S; Sundar D
J Struct Biol; 2024 Jun; 216(2):108087. PubMed ID: 38494148
[TBL] [Abstract][Full Text] [Related]
10. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
Elife; 2021 Aug; 10():. PubMed ID: 34435953
[TBL] [Abstract][Full Text] [Related]
11. Examining sialic acid derivatives as potential inhibitors of SARS-CoV-2 spike protein receptor binding domain.
Banerjee T; Gosai A; Yousefi N; Garibay OO; Seal S; Balasubramanian G
J Biomol Struct Dyn; 2024 Aug; 42(12):6342-6358. PubMed ID: 37424217
[TBL] [Abstract][Full Text] [Related]
12. Molecular insights into the binding variance of the SARS-CoV-2 spike with human, cat and dog ACE2 proteins.
Zang Y; Li X; Zhao Y; Wang H; Hao D; Zhang L; Yang Z; Yuan X; Zhang S
Phys Chem Chem Phys; 2021 Jun; 23(24):13752-13759. PubMed ID: 34132301
[TBL] [Abstract][Full Text] [Related]
13. Why Does the Novel Coronavirus Spike Protein Interact so Strongly with the Human ACE2? A Thermodynamic Answer.
de Andrade J; Gonçalves PFB; Netz PA
Chembiochem; 2021 Mar; 22(5):865-875. PubMed ID: 33084150
[TBL] [Abstract][Full Text] [Related]
14. Comparative molecular dynamics study of the receptor-binding domains in SARS-CoV-2 and SARS-CoV and the effects of mutations on the binding affinity.
Rezaei S; Sefidbakht Y; Uskoković V
J Biomol Struct Dyn; 2022 Jul; 40(10):4662-4681. PubMed ID: 33331243
[TBL] [Abstract][Full Text] [Related]
15. Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern.
Kim S; Liu Y; Lei Z; Dicker J; Cao Y; Zhang XF; Im W
J Chem Theory Comput; 2021 Dec; 17(12):7972-7979. PubMed ID: 34856802
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.
Zahradník J; Marciano S; Shemesh M; Zoler E; Harari D; Chiaravalli J; Meyer B; Rudich Y; Li C; Marton I; Dym O; Elad N; Lewis MG; Andersen H; Gagne M; Seder RA; Douek DC; Schreiber G
Nat Microbiol; 2021 Sep; 6(9):1188-1198. PubMed ID: 34400835
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of molecular interaction, physicochemical parameters and conserved pattern of SARS-CoV-2 Spike RBD and hACE2: in silico and molecular dynamics approach.
Chakraborty C; Sharma AR; Mallick B; Bhattacharya M; Sharma G; Lee SS
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1708-1723. PubMed ID: 33629340
[TBL] [Abstract][Full Text] [Related]
18. Emerging of composition variations of SARS-CoV-2 spike protein and human ACE2 contribute to the level of infection:
AlGhamdi NA; Alsuwat HS; Borgio JF; AbdulAzeez S
J Biomol Struct Dyn; 2022 Apr; 40(6):2635-2646. PubMed ID: 33138699
[TBL] [Abstract][Full Text] [Related]
19. Site Density Functional Theory and Structural Bioinformatics Analysis of the SARS-CoV Spike Protein and hACE2 Complex.
Kumawat N; Tucs A; Bera S; Chuev GN; Valiev M; Fedotova MV; Kruchinin SE; Tsuda K; Sljoka A; Chakraborty A
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164065
[TBL] [Abstract][Full Text] [Related]
20. Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages.
Kalathiya U; Padariya M; Fahraeus R; Chakraborti S; Hupp TR
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33671255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]